Search Results - "Cancer biotherapy & radiopharmaceuticals"
-
1
Exosomal circFBLIM1 Promotes Hepatocellular Carcinoma Progression and Glycolysis by Regulating the miR-338/LRP6 Axis
Published in Cancer biotherapy & radiopharmaceuticals (01-12-2023)“…Hepatocellular carcinoma (HCC) is the most common form of liver cancer. Circular RNAs (circRNAs) play a vital role in cancer development and progression. This…”
Get more information
Journal Article -
2
Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches
Published in Cancer biotherapy & radiopharmaceuticals (01-10-2018)“…The α-emitting radionuclide actinium-225 possesses nuclear properties that are highly promising for use in targeted α therapy (TAT), a therapeutic strategy…”
Get more information
Journal Article -
3
Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/ ZIC5 Axis in Glioma
Published in Cancer biotherapy & radiopharmaceuticals (01-09-2021)“…The resistance of glioma patients to temozolomide (TMZ) treatment is a limiting factor in clinical treatment. Circular RNA HIPK3 (circ-HIPK3) was found to be…”
Get more information
Journal Article -
4
Circ_0004913 Inhibits Cell Growth, Metastasis, and Glycolysis by Absorbing miR-184 to Regulate HAMP in Hepatocellular Carcinoma
Published in Cancer biotherapy & radiopharmaceuticals (01-12-2023)“…Circular RNA (circRNA) can regulate the progression of hepatocellular carcinoma (HCC). However, the role and potential mechanism of circ_0004913 in HCC are not…”
Get more information
Journal Article -
5
Targeted Alpha Therapy: Current Clinical Applications
Published in Cancer biotherapy & radiopharmaceuticals (01-08-2020)“…α-Emitting radionuclides have been approved for cancer treatment since 2013, with increasing degrees of success. Despite this clinical utility, little is known…”
Get more information
Journal Article -
6
The Role of miRNA in the Diagnosis, Prognosis, and Treatment of Osteosarcoma
Published in Cancer biotherapy & radiopharmaceuticals (01-12-2019)“…Osteosarcoma (OS) is one of the most common malignant tumors derived from mesenchymal tissue and is highly invasive, mainly in children and adolescents…”
Get more information
Journal Article -
7
Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis
Published in Cancer biotherapy & radiopharmaceuticals (01-03-2022)“…Non-small cell lung cancer (NSCLC) is the most prevalent cancer in the world. Chemotherapy resistance is a major obstacle to NSCLC therapy. This study explored…”
Get more information
Journal Article -
8
Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure
Published in Cancer biotherapy & radiopharmaceuticals (01-08-2020)“…Despite the consensus around the clinical potential of the α-emitting radionuclide astatine-211 ( At), there are only a limited number of research facilities…”
Get more information
Journal Article -
9
Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA
Published in Cancer biotherapy & radiopharmaceuticals (01-12-2022)“…Colorectal cancer (CRC) is one of the most common cancers worldwide. In this study, we explored the role of RNA binding motif protein 15 (RBM15)-mediated MyD88…”
Get more information
Journal Article -
10
Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future Perspectives
Published in Cancer biotherapy & radiopharmaceuticals (01-06-2017)“…Nowadays, colorectal cancer is the fourth most common type of tumor all over the world. When diagnosed, ∼50%-60% of tumors have metastasized, thus resulting in…”
Get more information
Journal Article -
11
Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway
Published in Cancer biotherapy & radiopharmaceuticals (01-09-2021)“…Temozolomide (TMZ) resistance is a serious hindrance in clinical chemotherapy for glioma. Circular RNA homeodomain interacting protein kinase 3 (circHIPK3) can…”
Get more information
Journal Article -
12
Matrine Inhibits Proliferation, Invasion, and Migration and Induces Apoptosis of Colorectal Cancer Cells Via miR-10b/PTEN Pathway
Published in Cancer biotherapy & radiopharmaceuticals (01-12-2022)“…Colorectal cancer (CRC) is the third most common malignancy worldwide. Matrine can act as a potential antitumor drug, and its antitumor activities have been…”
Get more information
Journal Article -
13
Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating ABCC1 Through miR-186-5p
Published in Cancer biotherapy & radiopharmaceuticals (01-06-2023)“…Lung cancer is a social problem of increasing concern, and non-small cell lung cancer (NSCLC) accounts for 80%-85% incidence of lung cancer. Cisplatin (DDP) is…”
Get more information
Journal Article -
14
Circ_0109291 Promotes Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase ABCB1 Expression
Published in Cancer biotherapy & radiopharmaceuticals (01-05-2022)“…The occurrence of cisplatin (DDP) resistance in oral squamous cell carcinoma (OSCC) is a major challenge for OSCC treatment. Circular RNAs (circRNAs) have been…”
Get more information
Journal Article -
15
Long Noncoding RNAs PTPRG Antisense RNA 1 Targets Cyclin D1 to Facilitate Cell Proliferation in Lung Adenocarcinoma
Published in Cancer biotherapy & radiopharmaceuticals (01-10-2024)“…Numerous studies have recorded the function of long noncoding RNAs (lncRNAs) in cancer development, including lung adenocarcinoma (LUAD). Previous studies have…”
Get more information
Journal Article -
16
Circle RNA circABCB10 Modulates PFN2 to Promote Breast Cancer Progression, as Well as Aggravate Radioresistance Through Facilitating Glycolytic Metabolism Via miR-223-3p
Published in Cancer biotherapy & radiopharmaceuticals (01-08-2021)“…Breast cancer (BC) is a common tumor in women worldwide, and irradiation (IR) resistance is a major obstacle for BC therapy. Circle RNAs (circRNAs) were…”
Get more information
Journal Article -
17
Serum-Derived Exosomes-Mediated Circular RNA ARHGAP10 Modulates the Progression of Non-Small Cell Lung Cancer Through the miR-638/FAM83F Axis
Published in Cancer biotherapy & radiopharmaceuticals (01-03-2022)“…Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths all over the world. Exosomes exert central roles in intercellular communication…”
Get more information
Journal Article -
18
Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy
Published in Cancer biotherapy & radiopharmaceuticals (01-09-2020)“…Targeted α therapy (TAT) offers the potential for the targeted delivery of potent α-particle-emitting radionuclides that emit high linear energy transfer…”
Get more information
Journal Article -
19
miR-141-5p Affects the Cell Proliferation and Apoptosis by Targeting BTG1 in Cervical Cancer
Published in Cancer biotherapy & radiopharmaceuticals (01-08-2024)“…MicroRNAs have been discovered to have the possibility to play a significant role in cancer development. While miR-141-5p has been found upregulated in various…”
Get more information
Journal Article -
20
Targeted Alpha Therapy with Thorium-227
Published in Cancer biotherapy & radiopharmaceuticals (01-08-2020)“…Targeted alpha therapy (TAT) can deliver high localized burden of radiation selectively to cancer cells as well as the tumor microenvironment, while minimizing…”
Get more information
Journal Article